SLEEPING BEAUTY-MEDIATED ENGINEERING OF CYTOKINE INDUCED KILLER (CIK) CELLS WITH CHIMERIC ANTIGEN RECEPTORS (CARS) FOR IMMUNOTHERAPY OF ACUTE LEUKEMIAS

被引:0
|
作者
Magnani, C. F. F. [1 ]
Turazzi, N. [1 ]
Benedicenti, F. [2 ]
Tettamanti, S. [1 ]
Attianese, G. M. P. Giordano [1 ,3 ]
Rossi, V. [1 ]
Montini, E. [2 ]
Cooper, L. J. [3 ]
Aiuti, A. [2 ]
Biondi, A. [1 ]
Biagi, E. [1 ]
机构
[1] Univ Milano Bicocca, Osp San Gerardo Fdn MBBM, Ctr Ric Tettamanti, Pediat Clin, Monza, Italy
[2] San Raffaele Telethon Inst Gene Therapy HSR TIGET, Milan, Italy
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
S746
引用
收藏
页码:270 / 270
页数:1
相关论文
共 50 条
  • [31] Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System
    Bauser, Maximilian
    Einsele, Hermann
    Loeffler, Juergen
    Hudecek, Michael
    Seif, Michelle
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2024, (212):
  • [32] Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform
    Magnani, Chiara F.
    Turazzi, Nice
    Benedicenti, Fabrizio
    Calabria, Andrea
    Tenderini, Erika
    Tettamanti, Sarah
    Attianese, Greta M. P. Giordano
    Cooper, Laurence J. N.
    Aiuti, Alessandro
    Montini, Eugenio
    Biondi, Andrea
    Biagi, Ettore
    ONCOTARGET, 2016, 7 (32) : 51581 - 51597
  • [33] Immunotherapy of Acute Leukemia by Chimeric Antigen Receptor-Modified Lymphocytes Using an Improved Sleeping Beauty Transposon Platform
    Magnani, C. F.
    Turazzi, N.
    Tettamanti, S.
    Montini, E.
    Biondi, A.
    Biagi, E.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S37 - S37
  • [34] Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors
    Mesiano, Giulia
    Todorovic, Maja
    Gammaitoni, Loretta
    Leuci, Valeria
    Diego, Lidia Giraudo
    Carnevale-Schianca, Fabrizio
    Fagioli, Franca
    Piacibello, Wanda
    Aglietta, Massimo
    Sangiolo, Dario
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (06) : 673 - 684
  • [35] SPECIFIC TARGETING OF ACUTE MYELOID LEUKEMIA BY THE USE OF ENGINEERED CIK (CYTOKINE-INDUCED KILLER) CELLS EXPRESSING THE ANTI-CD33 CHIMERIC ANTIGEN RECEPTOR (CAR)
    Rotiroti, M. C.
    Arcangeli, S.
    Magnani, C. F.
    Cappuzzello, C.
    Biondi, A.
    Tettamanti, S.
    Biagi, E.
    HAEMATOLOGICA, 2016, 101 : S42 - S42
  • [36] SPECIFIC TARGETING OF ACUTE MYELOID LEUKEMIA BY THE USE OF ENGINEERED CIK (CYTOKINE-INDUCED KILLER) CELLS EXPRESSING THE ANTI-CD33 CHIMERIC ANTIGEN RECEPTOR (CAR)
    Rotiroti, M. C.
    Arcangeli, S.
    Magnani, C. F.
    Cappuzzello, C.
    Biondi, A.
    Tettamanti, S.
    Biagi, E.
    HAEMATOLOGICA, 2017, 102 : 247 - 248
  • [37] Specific Targeting of Acute Myeloid Leukemia by the use of Engineered CIK (Cytokine-Induced Killer) Cells Expressing the Anti-CD33 Chimeric Antigen Receptor (CAR)
    Rotiroti, M. C.
    Arcangeli, S.
    Magnani, C. F.
    Cappuzzello, C.
    Biondi, A.
    Tettamanti, S.
    Biagi, E.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S54 - S55
  • [38] CYTOKINE INDUCED KILLER (CIK) CELLS FOR CELL THERAPY OF ACUTE MYELOID LEUKEMIA (AML): IMPROVEMENT OF IMMUNE ACTIVITY BY EXPRESSION OF CD33-SPECIFIC CHIMERIC RECEPTORS (CAR)
    Marin, V.
    Pizzitola, I.
    Agostoni, V.
    Pule, M.
    Rousseau, R.
    Lawson, A.
    Finney, H.
    Biondi, A.
    Biagi, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 305 - 305
  • [39] Expression of a chimeric antigen receptor (CAR) specific for the CD33 antigen on Cytokine Induced Killer (CIK) cells radically improves their anti-leukemic activity
    Marin, Virna
    Pizzitola, Irene
    Agostoni, Valentina
    Pule, Martin
    Rousseau, Raphael
    Biondi, Andrea
    Biagi, Ettore
    HUMAN GENE THERAPY, 2008, 19 (10) : 1085 - 1085
  • [40] Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatment
    Bahmanyar, Maryam
    Vakil, Mohammad Kazem
    Al-Awsi, Ghaidaa Raheem Lateef
    Kouhpayeh, Seyed Amin
    Mansoori, Yaser
    Mansoori, Behnam
    Moravej, Ali
    Mazarzaei, Abdulbaset
    Ghasemian, Abdolmajid
    BMC CANCER, 2022, 22 (01)